Filing Flows › Companies › Elanco Animal Health › Timeline
Elanco Animal Health stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+19.6% to $25.74
Elanco Animal Health (ELAN) stock rose 20% over the last 252 sessions, to $25.74. On the way it reported 4 quarters, its insiders filed 7 open-market trades and 1 Form 144 notice of planned sales, and the company filed 1 material 8-K. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 6, 2026 | Earnings | Earnings: beat the EPS estimate by 32.8% | +8.3% (+8.0% vs SPY) | — | — |
| Oct 15, 2026 | Form 144 | Form 144: Timothy J Bettington plans to sell $100K | +4.3% (+4.0% vs SPY) | 0.0% (−0.4% vs SPY) | — |
| Aug 20, 2026 | Insider buy | Kurzius Lawrence Erik bought $936K | −3.9% (−3.1% vs SPY) | +2.3% (+2.7% vs SPY) | −8.9% (−8.1% vs SPY) |
| Aug 18, 2026 | Insider buy | O'Neill Shiv bought $94K | +0.1% (+0.8% vs SPY) | +3.4% (+4.6% vs SPY) | −3.2% (−0.8% vs SPY) |
| Aug 12, 2026 | Insider buy | Harrington Michael J bought $109K | −2.7% (−2.9% vs SPY) | +3.9% (+4.3% vs SPY) | +0.6% (+2.2% vs SPY) |
| Aug 7, 2026 | Insider buy | VanHimbergen Robert M bought $97K | −9.0% (−9.6% vs SPY) | −7.2% (−8.5% vs SPY) | +1.2% (+1.0% vs SPY) |
| Aug 7, 2026 | Insider buy | Herendeen Paul bought $237K | −9.0% (−9.6% vs SPY) | −7.2% (−8.5% vs SPY) | +1.2% (+1.0% vs SPY) |
| Aug 5, 2026 | Earnings | Earnings: beat the EPS estimate by 26.5% | +2.4% (+2.6% vs SPY) | −11.9% (−11.8% vs SPY) | −3.7% (−2.9% vs SPY) |
| May 15, 2026 | Insider buy | Simmons Jeffrey N bought $100K | −8.6% (−7.4% vs SPY) | −1.5% (−0.7% vs SPY) | +11.6% (+10.7% vs SPY) |
| May 15, 2026 | Insider buy | Modi Rajeev A. bought $100K | −8.6% (−7.4% vs SPY) | −1.5% (−0.7% vs SPY) | +11.6% (+10.7% vs SPY) |
| May 6, 2026 | Earnings | Earnings: beat the EPS estimate by 16.6% | +13.0% (+11.6% vs SPY) | −7.0% (−9.0% vs SPY) | +7.2% (+2.7% vs SPY) |
| Feb 24, 2026 | Earnings | Earnings: beat the EPS estimate by 11.2% | +6.4% (+5.7% vs SPY) | +5.3% (+4.7% vs SPY) | +0.6% (+4.8% vs SPY) |
| Dec 9, 2025 | 8-K | Exit or disposal costs | −6.0% (−5.9% vs SPY) | +0.1% (+0.5% vs SPY) | +6.9% (+5.8% vs SPY) |
Insiders’ record here
In the year on the chart, Elanco Animal Health's insiders reported 7 open-market buys ($1.7M) and 0 sales ($0). Of the 4 old enough to score, 4 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was +14.3% and after a sale —.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 2.05 Exit or disposal costs | 954 | −0.2% | 47% | +0.5% | ±2.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Elanco Animal Health: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.